Change in Patient-Reported Outcomes in Severe Eosinophilic Asthma Patients Treated With Benralizumab Under Real-life Conditions

NCT04184284 · clinicaltrials.gov ↗
COMPLETED
Status
246
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AstraZeneca